iRobot Reports Third-Quarter 2024 Financial Results
Continues to Make Progress on “iRobot Elevate” Strategy Revises Full-year 2024 Outlook BEDFORD, Mass., Nov. 6, 2024 /PRNewswire/ — iRobot Corp.... Read more.
Clarivate Reports Third Quarter 2024 Results
LONDON, Nov. 6, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a leading global provider of transformative... Read more.
Propel Holdings named one of Canada’s Enterprise-Industry Leaders winners in Deloitte’s Technology Fast 50 program
TORONTO, Nov. 6, 2024 /CNW/ – Propel Holdings Inc. (“Propel” or the “Company”) (TSX: PRL) was honored as an Enterprise—Industry Leaders... Read more.
MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis
BEIJING, Nov. 6, 2024 /PRNewswire/ — MEGAROBO, a leading provider of advanced productivity tools for life sciences, has recently unveiled the CellVue™ T2000... Read more.
GoBolt Secures No. 2 Spot on Deloitte’s Technology Fast 50 List
823% growth from 2019 to 2023 earned GoBolt the 2nd spot in the Enterprise—Industry Leaders category in the 2024 Deloitte Technology Fast 50 program TORONTO, Nov.... Read more.
Esaote Group expands production in India
Innovative series of ultrasound systems are now “Made in India” at the new manufacturing site of subsidiary Esaote Asia Pacific Diagnostic Private Limited... Read more.
GoBolt Secures No. 2 Spot on Deloitte’s Technology Fast 50 List
823% growth from 2019 to 2023 earned GoBolt the 2nd spot in the Enterprise—Industry Leaders category in the 2024 Deloitte Technology Fast 50 program TORONTO, Nov.... Read more.
Lightspeed Ranked 5th Fastest Growing Enterprise–Industry Leader in Deloitte’s 2024 Technology Fast 50™ Program
MONTREAL, Nov. 6, 2024 /PRNewswire/ – Lightspeed Commerce Inc. (NYSE: LSPD) (TSX: LSPD) (“Lightspeed” or the “Company“), the one-stop... Read more.
Sand Technologies Partners with Envision Racing to Launch AI Solutions for Accelerated Impact
The global AI solutions company will work with the Formula E race team to develop AI tools that drive results and advance the team’s broader sustainability... Read more.
Minghui Pharmaceutical Announces Promising Initial Results from Phase I Clinical Trial of MHB039A, a Novel PD-1 x VEGF Bispecific Antibody, in Patients with Relapsed/Refractory Solid Tumors
SHANGHAI, Nov. 6, 2024 /PRNewswire/ — Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company focused on developing transformative medicines in... Read more.